相关实验视频

Updated: Jun 18, 2025

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

克罗门:在抗阿尔茨海默氏症药物发现的新兴支架

Uma Agarwal¹, Saroj Verma², Rajiv K Tonk¹

¹Department of Pharmaceutical Chemistry, Delhi Pharmaceutical Sciences & Research University, Delhi 110017, India.

Bioorganic & medicinal chemistry letters

|August 1, 2024

概括

天然和合成的克罗门在阿尔茨海默病 (AD) 治疗方面表现有前途. 本综述详细介绍了它们的合成,像乙胆酶 (AChE) 这样的点,以及药物开发的结构-活性关系 (SAR).

科学领域:

药用化学医学化学
神经科学是一个神经科学.
药理学药理学是指药理学的学科.

背景情况:

阿尔茨海默病 (AD) 是一个重大的全球健康挑战.
天然和合成的Chromenones被研究为潜在的多向药物候选药物,用于AD.
现有研究强调了各种具有治疗潜力的烯衍生物.

研究的目的:

综合审查用于阿尔茨海默病治疗的天然,半合成和合成.
阐明这些化合物的合成路径,药物点和结构-活性关系 (SAR).
为开发针对AD的基于门的新型治疗方法提供见解.

主要方法:

关于天然和合成烯及其衍生物的文献评论.
合成方法的分析,包括珀金和佩克曼凝结.
对与AD相关的关键标,如乙胆酶 (AChE),丁胆酶 (BuChE),BACE-1和单胺氧化酶 (MAO-A/B) 进行报告活动的检查.

主要成果:

天然的烯如奎尔和斯科波,以及合成混合物 (例如,阿克里丁,库马林,塔克林) 是有前途的.
克罗门混合体对多个AD目标表现出活性.
结构-活性关系 (SAR) 研究为优化治疗潜力的基础.

结论:

克罗门代表了开发针对阿尔茨海默病的多向药物的多功能支架.
了解合成途径和SAR对于设计有效的基于的疗法至关重要.
对克罗门杂交物的进一步研究可能会导致对阿尔茨海默病的新治疗方法.

关键词:

这是一种2H-Chromen-2-one.4H--4-一个.阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.这是一种Chromenone杂交物.库马林是一种素.毒品的目标是毒品.结构活动关系结构活动关系综合方案综合方案

更多相关视频

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...